- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07635628
Motivational Interviewing on Diet, Lifestyle and Gestational Weight Gain of Pregnant Women (GLOW)
Effectiveness on Gestational Weight Gain of Pregnant Women of Motivational Interviewing on Diet and Lifestyle: a Randomized Controlled Trial
It is widely recognized that nutrition, metabolism and physical activity during pregnancy play a central role in several aspects of the health and well-being of pregnant women and their offspring. Pre-pregnancy Body Mass Index (BMI) and Gestational Weight Gain (GWG) are important predictors of maternal and neonatal health outcomes. In particular, excessive maternal pre-pregnancy BMI (BMI ≥ 25) and GWG outside the range recommended by the Institute of Medicine (IOM), may put mothers at risk of complications during pregnancy and delivery and can affect the short and long-term health of the offspring. They are also predicting factors of postpartum weight retention and long-term risk of offspring overweight or higher BMI. Similarly to obesity, also maternal pre-pregnancy underweight can cause negative health effects with short and long-term consequences for the mother and the foetus.
The most recent scientific evidence acknowledges the complex interplay between factors that influence the nutritional status and GWG of pregnant women, suggesting the need for multifaceted interventions that include counselling approaches, implemented during routine antenatal care for broad public health benefits. In particular, interventions based on health-related behavioural changes such as motivational interviewing (MI), used to address motivation, self-efficacy and self-regulation, have shown to have high chances of success. MI is a person-centred technique for communication that is effective for overcoming ambivalence and eliciting motivation for change.
The starting hypothesis is that inadequate GWG at the end of pregnancy may bear some relation with dietary habits and lifestyle before and during pregnancy and that MI might be effective in initiating and sustaining behavioural changes, including weight control. The study will compare a group of pregnant women, randomly assigned to receive, as part of the hospital-based prenatal care program, a behavioral intervention based on the MI methodology focused on dietary habits and lifestyle, with a group of women randomly assigned to the standard prenatal care program. It is expected that the dietary habits of women in the MI group will change as a result of the intervention, and that the resulting effective management of weight gain during pregnancy will contribute to improved maternal and neonatal outcomes.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Trieste, Italien, 34137
- Institute for Maternal and Child Health - IRCCS "Burlo Garofolo"
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Pregnant women >=18 years, accessing hospital for the first scheduled ultrasound scan at 11-13 weeks of gestation and who express the intention of giving birth in the recruiting hospital
Exclusion Criteria:
- gestational age at enrollment > 15 weeks
- preexisting type 1 diabetes
- multiple pregnancy
- insufficient knowledge of the Italian language.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Experimental Group (EG)
In addition to usual antenatal care (UC), the Experimental Group (EG) will receive four prenatal MI sessions between 11 and 15 weeks of gestation (T1), between 18 and 22 weeks (T2), between 24 and 28 weeks (T3), and between 30 and 34 weeks (T4).
|
The four MI sessions, centered on eating habits, physical activity and lifestyle behaviours, will be led by a multidisciplinary group of health professionals - dieticians/nutritionists/ expert in motor sciences/psychologist - trained by a psychologist with expertise in MI.
During the motivational sessions, personal barriers to behavioural change will be explored and positive verbal reinforcement will be given to increase self-confidence and self-efficacy.
Women will be asked to identify the lifestyle behaviours they need to change and to set small stepwise goals based on their own intention to achieve a healthier lifestyle.
Weight will be measured and GWG monitored at each of the four sessions.
|
|
Inget ingripande: Control Group (CG)
The Control Group (CG) will only receive the usual antenatal care (UC)
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Percentage of Women With Adequate Gestational Weight Gain According to Institute of Medicine Guidelines
Tidsram: At delivery
|
Gestational weight gain will be calculated as maternal weight at delivery minus self-reported pre-pregnancy weight. Adequate gestational weight gain will be defined according to the Institute of Medicine guidelines, based on pre-pregnancy body mass index category. The outcome will be reported as the percentage of women with gestational weight gain within the recommended range: number of women with adequate gestational weight gain / total number of women assessed x100 |
At delivery
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Gestational age at delivery
Tidsram: At delivery
|
Gestational age at delivery will be calculated in completed weeks of gestation, based on the first day of the last menstrual period and/or obstetric dating.
The outcome will be reported as a continuous variable.
|
At delivery
|
|
Mode of delivery
Tidsram: At delivery
|
Mode of delivery will be categorized as spontaneous vaginal delivery, assisted vaginal delivery by vacuum or forceps, or cesarean delivery.
The outcome will be reported as the number and percentage of women in each category.
|
At delivery
|
|
Newborn birth weight
Tidsram: within 30 minute after birth
|
Newborn birth weight will be measured in grams and abstracted from the delivery or neonatal medical record.
The outcome will be reported as a continuous variable
|
within 30 minute after birth
|
|
Newborn birth length
Tidsram: within 30 minute after birth
|
Newborn birth length will be measured in centimeters and abstracted from the delivery or neonatal medical record.
The outcome will be reported as a continuous variable
|
within 30 minute after birth
|
|
Apgar Score at 1 Minute After Birth
Tidsram: 1 minutes after birth
|
Neonatal well-being will be assessed using the Apgar score at 1 minute after birth.
The Apgar score ranges from 0 to 10, with higher scores indicating better neonatal condition.
The outcome will be reported as a score or, if pre-specified, as the number and percentage of newborns with Apgar score less than 7
|
1 minutes after birth
|
|
Apgar Score at 5 Minute After Birth
Tidsram: 5 minutes after birth
|
Neonatal well-being will be assessed using the Apgar score at 5 minute after birth.
The Apgar score ranges from 0 to 10, with higher scores indicating better neonatal condition.
The outcome will be reported as a score or, if pre-specified, as the number and percentage of newborns with Apgar score less than 7
|
5 minutes after birth
|
|
Exclusive breastfeeding at Hospital Discharge
Tidsram: At hospital discharge, expected within 2-5 days after delivery
|
Exclusive breastfeeding at hospital discharge will be defined as the newborn receiving only breast milk, with no formula or other liquids/foods, except medications or vitamin/mineral supplements if applicable.
The outcome will be reported as the percentage of mother-newborn dyads with exclusive breastfeeding at discharge.
|
At hospital discharge, expected within 2-5 days after delivery
|
|
Change in Dietary Behaviours from Baseline to 34 Weeks of Gestation
Tidsram: Baseline and 34 weeks of gestation
|
Differences in consumption frequency by food group.
To evaluate consumption frequency a validated self-reported food frequency questionnaire will be used Dietary behaviours will be assessed using a validated self-reported food frequency questionnaire.
Dietary behaviours changes will be evaluated within and between groups and compared with the national dietary recommendations.
The outcome will be reported as the change from baseline to 34 weeks of gestation.
|
Baseline and 34 weeks of gestation
|
|
Gestational Weight Gain at 18-22 Weeks of Gestation
Tidsram: 18 weeks 0 days to 22 weeks 6 days of gestation
|
Gestational weight gain at 18-22 weeks of gestation will be calculated as maternal weight measured between 18 weeks 0 days and 22 weeks 6 days of gestation minus self-reported pre-pregnancy weight.
The outcome will be reported in kilograms
|
18 weeks 0 days to 22 weeks 6 days of gestation
|
|
Gestational Weight Gain at 24-28 Weeks of Gestation
Tidsram: 24 weeks 0 days to 28 weeks 6 days of gestation.
|
Gestational weight gain at 24-28 weeks of gestation will be calculated as maternal weight measured between 24 weeks 0 days and 28 weeks 6 days of gestation minus self-reported pre-pregnancy weight.
The outcome will be reported in kilograms
|
24 weeks 0 days to 28 weeks 6 days of gestation.
|
|
Gestational Weight Gain at 30-34 Weeks of Gestation
Tidsram: 30 weeks 0 days to 34 weeks 6 days of gestation.
|
Gestational weight gain at 30-34 weeks of gestation will be calculated as maternal weight measured between 30 weeks 0 days and 34 weeks 6 days of gestation minus self-reported pre-pregnancy weight.
The outcome will be reported in kilograms
|
30 weeks 0 days to 34 weeks 6 days of gestation.
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Paola Pani, PhD, Institute for Maternal and Child Health IRCCS Burlo Garofolo
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- RC 07/24
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .